CJC‑1295 without DAC 5mg

CJC‑1295 without DAC, also known as Mod GRF 1‑29, is a short‑acting growth hormone–releasing hormone (GHRH) analogue used extensively in endocrine and metabolic research. This modified 29‑amino‑acid peptide is engineered to enhance the stability of native GHRH while maintaining a physiological, pulsatile release profile. It is ideal for controlled laboratory studies requiring precision, purity, and reproducibility.

• Product Name: CJC‑1295 without DAC 5mg
• Catalogue Number: CJC1295ND-005
• Molecular Formula: C152H252N44O42
• CAS Number: 863288‑34‑0
• Molecular Weight: 3367.97 g/mol
• Purity: ≥99%
• Compound Type: GHRH Analogue / Peptide
• Form: Lyophilised Peptide Powder – What is this? Read more here.

Why Is CJC‑1295 without DAC of Interest to the Research Community?

CJC‑1295 without DAC (Mod GRF 1‑29) is a modified form of the first 29 amino acids of endogenous GHRH. It incorporates strategic substitutions to improve stability while preserving the natural, short‑acting behaviour of native GHRH. Unlike the DAC‑modified version, which binds to albumin for prolonged activity, the non‑DAC form has a short half‑life—typically 5–30 minutes—making it ideal for research focused on:

• pulsatile growth hormone (GH) secretion and physiological GH rhythms
• pituitary responsiveness to short‑acting GHRH analogues
• synergistic GH release when combined with GHRPs such as Ipamorelin
• metabolic and anabolic pathways influenced by GH signalling
• age‑related changes in GH production and endocrine function

Its rapid onset and short duration allow researchers to model natural GH pulses with high temporal precision, making it a valuable tool in endocrinology, metabolism, and recovery‑related studies.

Usage and Storage:

CJC‑1295 without DAC is supplied as a lyophilised peptide powder to ensure maximum stability and ease of handling in research environments. For best results, follow our website’s detailed reconstitution and storage guidelines.

Learn more about peptide storage

Synthesis and Quality Assurance:

Our CJC‑1295 without DAC is synthesised using controlled peptide manufacturing processes designed to ensure high purity, structural accuracy, and batch‑to‑batch consistency. Each batch undergoes stringent purification and analytical testing to meet the rigorous standards required for advanced scientific research.

Why Choose Simply Peptides for CJC‑1295 without DAC in the UK?

Simply Peptides is committed to providing research‑grade compounds of uncompromising quality. Through direct manufacturing partnerships, we maintain full oversight of production standards and batch consistency. Researchers across the UK and internationally trust our transparent testing, rigorous quality control, and dependable supply chain.

Is This Product for Human Use?

No. This material is for research only and is not intended for human consumption or clinical applications.

External Resources for Researchers

• PubMed — Mod GRF 1‑29 (search)
• Google Scholar — CJC‑1295 without DAC literature

Alternative Names for CJC‑1295 without DAC

• Mod GRF 1‑29 – Most common research name
• Modified GRF 1‑29
• CJC‑1295 without DAC
• Tetrasubstituted GRF (1‑29)

Legal and Safety Information:

Simply Peptides supplies CJC‑1295 without DAC strictly for scientific and research use. Our products are not intended for human consumption or clinical application. We uphold stringent quality and legal compliance standards to support the research community.

COA & Testing Reports

Certificate of Analysis (COA) & Independent Testing

Each batch of CJC‑1295 without DAC is accompanied by a Certificate of Analysis (COA), verifying identity, purity, and composition using validated analytical methods. This ensures transparency and supports research integrity.

In addition to internal quality control, we commission independent third‑party analysis to confirm peptide purity, molecular weight, and absence of contaminants. These reports are available upon request to qualified research professionals.

• Batch‑specific COA are available for download or review here
• Third‑party lab testing for purity and identity confirmation are available here
• Analytical methods include HPLC, Mass Spectrometry, and Microbial Screening here

Note: All documentation is provided for research reference only and is not intended to support clinical or therapeutic claims.